What disease management offers to patients and reps.
Disease management provides salespeople with the opportunity to become key members of the patient care team. Disease management aims to improve health outcomes and focuses on diseases that require care instead of cures, such as diabetes and asthma.
There are four major principles of disease management:
1. Understanding the disease's course, causes, patterns and cost drivers: This involves conducting a needs assessment to define who the end users are.
It is often necessary to survey the patient pool for age, socioeconomic status and health-related habits to find common chronic conditions that can be targeted for disease management programs.
2. Performing Diagnosis and treatment: This step involves gathering and evaluating key medical information, or evidence. Treatment recommendations, or clinical practice guidelines, should be made based on the evidence.
3. Educating for compliance: By educating doctors and patients, we can improve patient compliance and care. Salespeople's role of educating doctors and patients will expand a great deal through disease management.
4. Working toward cost-effective treatments: Realistic clinical outcomes studies will help provide us with the best and most cost-effective treatments.
In order for these clinical studies to be effective, they need to include economic, clinical and humanistic criteria.
The beauty of the disease management process is not only is it a more cost-effective approach - it is a more effective therapy approach.
Patients benefit by improved functional well-being, consideration of their human needs, education and empowerment, because they are very active in their own treatment. PR
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Asembia 2025: Therapy Advancements Highlight Growing Cost and Access Concerns
April 30th 2025Fran Gregory, VP, emerging therapies, Cardinal Health, discusses the evolving cell and gene therapy landscape, highlighting pipeline growth, cost challenges, and emerging therapeutic areas beyond oncology and hematology.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.